InhaleRx secures up to $38.5m in funding for clinical trial program by Martin Lane October 18, 2024February 25, 2025 InhaleRx has entered into a loan agreement with Clendon Biotech Capital (CBC) to fund Phase 1 […]
Company news: ECS Botanics; Althea; InhaleRx; Neurotech International by Martin Lane and Steve Jones July 10, 2024July 11, 2024
Company news: Zelira Therapeutics; Ecofibre; Cann Group; InhaleRx; Argent Biopharma; Melodiol Global Health; Wellnex Life by Steve Jones July 4, 2024November 25, 2024
Company news: Medibis; Althea; Elixinol; InhaleRx; Ecofibre; Aura Therapeutics; AusCann by Martin Lane April 4, 2024July 16, 2024
Company news: Cann Global; Cann Group; InhaleRx; AusCann; Wellnex Life; Neurotech; MGC Pharma; Stenocare by Martin Lane December 4, 2023April 30, 2024
Cannvalate named in US fraud lawsuit as InhaleRx distances itself from legal stoush by Steve Jones November 16, 2023April 5, 2024
Company news: Breathe Life Sciences; Cann Group; InhaleRx; X-Hemp; Green Farmers/Elevated Signals by Martin Lane October 19, 2023April 30, 2024
Company news: Emyria; Ananda Wellness; InhaleRx; Cann Global; HFA by Steve Jones September 28, 2022April 29, 2024
